Novel <i>RCBTB1</i> variants causing later-onset non-syndromic retinal dystrophy with macular chorioretinal atrophy
Andrew J. Catomeris(Georgetown University), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Naomi E. Wagner(Massachusetts Eye and Ear Infirmary), Jason Comander(Massachusetts Eye and Ear Infirmary), Brian G. Ballios(University of Toronto), Eric A. Pierce(Broad Institute), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Emily Place(MACOM (United States)), Riccardo Sangermano(Radboud University Nijmegen)
Cited by 7
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k